Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person5
Biohaven Ltd.
Company
Zura Bio Ltd
Company
BingEx Ltd
Company
Entera Bio Ltd.
Company
BitVentures Ltd
Company
Primary record9
Biohaven Ltd. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On October 29, 2026, Biohaven Ltd. (the “ Registrant ”) issued a press release announcing its financial results for the third quarter ended September 30, 2026. A c
Biohaven Ltd. filed 8-K
Item 7.01 Regulation FD Disclosure. On October 22, 2026, Biohaven Ltd. (the Company) provided an update on the spinocerebeller ataxia (SCA) program. The FDA has informed Biohaven that the company’s new drug application r
Biohaven Ltd. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. Collaboration and License Agreement On October 8, 2026, Biohaven Ltd., together with its wholly owned subsidiaries (the Company ), entered into a Collaboration and L
Biohaven Ltd. filed 4
SEC form 4 filed by Biohaven Ltd. (CIK 1935979) on 2026-09-17.
Biohaven Ltd. filed 8-K
Item 8.01 Other Events. Biohaven Ltd. (the Company, we or our ) is providing updates to the BHV-7000 program. We refer you to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 for a description of the
Biohaven Ltd. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. License Agreement On August 26, 2026, Biohaven Bioscience Ireland Limited ( BBIL ), a wholly owned subsidiary of Biohaven Ltd. (the Company ), entered into a License
Biohaven Ltd. filed SCHEDULE 13G
, the beneficial owner of the Common Shares reported herein. The address of the business office of Woodline Partners is 4 Embarcadero Center, Suite 3450, San Francisco, CA 94111. Woodline Partners is a Delaware limited p
Biohaven Ltd. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On August 10, 2026, Biohaven Ltd. (the Registrant ) issued a press release announcing its financial results for the second quarter ended June 30, 2026. A copy of t
Biohaven Ltd. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 3, 2026, the Board of Directors (the Board ) of Bioha